For patients recovering from opioid use disorder, particularly from drugs like fentanyl or heroin, the days immediately following a hospital stay are among the most dangerous. A new multi-state study ...

A federal bankruptcy court judge on Tuesday formally approved OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the harms of opioids. U.S. Bankruptcy Judge Sean Lane gave ...

While the dangers of fentanyl have been dominating headlines for years, the death toll from another class of extremely potent synthetic opioids called “nitazenes” has been climbing steadily. For ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, are steadily becoming more common on both sides of the Atlantic. Nitazenes were first synthesized in the 1950s by CIBA ...

Researchers who study trends in illicit drug use are concerned that sales of a potent class of synthetic opioids called nitazenes are on the rise globally. The opioid class of drugs includes heroin ...

NJ gubernatorial candidate Rep. Mikie Sherrill accused Republican opponent Jack Ciattarelli of personally profiting off the opiate crisis in the tensest moment of Wednesday night’s debate. “My ...

A 2-GW nuclear power plant in New York State that was shut down in 2021 could be restarted, an official with Holtec International said. The Indian Point station, which sits near the Hudson River in ...

Opioid medications will be required to have their labeling updated to highlight the safety risks of long-term use, the FDA announced on Thursday. The agency is requiring opioid manufacturers to add to ...

Lev Facher covers the U.S. addiction and overdose crisis. The Food and Drug Administration will soon require prescription opioid manufacturers to include stronger language on the medications’ labels ...

Jerry Abrams, a 64-year-old marketing strategist in Minneapolis, used to run marathons. But two decades of degenerative spine disease have left him unable to run — and he's grieving. For Abrams, ...